+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis



Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis



Asian Pacific Journal of Cancer Prevention 15(17): 7419-7424



Gliomas are the most common type of primary brain tumors. The XRCC1 Arg194Trp variant affects the proliferating cell nuclear antigen( PCNA) binding region, which suggests that this mutation may contribute to gliomagenesis and a number of articles have examine the association between XRCC1 Arg194Trp and the susceptibility to glioma. However, the results were conflicting. Test of heterogeneity, sensitivity analysis, meta- analysis, and assessment of publication bias were all performed in our present meta-analysis, covering a total of 5,407 patients and 7,715 healthy persons. In the overall analysis the XRCC1 Arg194Trp polymorphism showed a significant association with glioma susceptibility in a recessive mode l(for TrpTrp vs ArgArg+ArgTrp: OR=1.918, 95%CI=1.575-2.336, I2=2.3%). In addition, analysis of subgroups presented an increased risk in Asians and populations-based on hospitals. The results suggested that the XRCC1 Arg194Trp polymorphism is a genetic risk factor for glioma, especially in Asian population. To further evaluate gene-gene and gene-environment interactions on XRCC1 polymorphisms and glioma risk, thousands of subjects and tissue-specific biochemical characterizations are required.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051678036

Download citation: RISBibTeXText

PMID: 25227852


Related references

No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis. Tumour Biology 35(6): 5629-5635, 2014

Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis. Oncotarget 8(13): 21599-21608, 2017

The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: A meta-analysis involving 1,440 cases and 2,562 controls. Experimental and Therapeutic Medicine 4(6): 1057-1062, 2012

XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis. Tumour Biology 34(4): 2321-2327, 2013

An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Asian Pacific Journal of Cancer Prevention 15(7): 3273-3278, 2014

The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Molecular Biology Reports 38(7): 4565-4573, 2011

Association between genetic polymorphism of XRCC1 Arg194Trp and risk of schizophrenia. Psychiatry Research 169(2): 186, 2009

Study on the association between the Arg194Trp polymorphism in the XRCC1 gene and the risk of hematological malignancies. Tumour Biology 35(4): 3009-3016, 2014

Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies. Tumour Biology 35(11): 10677-10697, 2014

DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta-analysis. Oncology Letters 8(4): 1725-1730, 2014

Association between XRCC1 polymorphism 399 G-A and glioma among Caucasians a systematic review and meta-analysis. BMC Medical Genetics 13(1): 97, 2012

Association between XRCC1 polymorphism 399 G->A and glioma among Caucasians: a systematic review and meta-analysis. Bmc Medical Genetics 13: 97, 2012

A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Molecular Biology Reports 40(1): 567-572, 2013

Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Rheumatology International 37(3): 435-444, 2017

XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24(4): 331-339, 2009